Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults

Benjamin Young, Margaret A. Fischl, Helene M. Wilson, Tyler S. Finn, Erin H. Jensen, Mark J. DiNubile, Robert K. Zeldin

Research output: Contribution to journalArticlepeer-review

27 Scopus citations

Fingerprint Dive into the research topics of 'Open-label study of a twice-daily indinavir 800-mg/ritonavir 100-mg regimen in protease inhibitor-naive HIV-infected adults'. Together they form a unique fingerprint.

Medicine & Life Sciences